Guardian Pharmacy Services (NYSE:GRDN) Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of Guardian Pharmacy Services (NYSE:GRDN) from a buy rating to a hold rating in a research note released on Sunday morning,Wall Street Zen reports.

Other equities analysts have also recently issued research reports about the stock. Weiss Ratings cut shares of Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday. KeyCorp initiated coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 price target for the company. Truist Financial upped their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Finally, Oppenheimer increased their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Nine equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $45.57.

Guardian Pharmacy Services Stock Performance

Shares of GRDN opened at $39.59 on Friday. The company’s 50-day simple moving average is $40.92 and its 200-day simple moving average is $37.86. Guardian Pharmacy Services has a 1 year low of $26.34 and a 1 year high of $48.33. The stock has a market capitalization of $1.97 billion, a PE ratio of 38.44 and a beta of 0.03.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The business had revenue of $351.77 million during the quarter, compared to analyst estimates of $340.45 million. On average, sell-side analysts predict that Guardian Pharmacy Services will post 1.18 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Jennison Associates LLC raised its holdings in shares of Guardian Pharmacy Services by 609.5% in the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after purchasing an additional 706,823 shares in the last quarter. Braun Stacey Associates Inc. acquired a new position in shares of Guardian Pharmacy Services during the second quarter worth $14,234,000. Ranger Investment Management L.P. acquired a new position in shares of Guardian Pharmacy Services during the second quarter worth $7,263,000. Dimensional Fund Advisors LP grew its stake in shares of Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after purchasing an additional 139,070 shares in the last quarter. Finally, Sei Investments Co. increased its holdings in Guardian Pharmacy Services by 40.5% in the first quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after buying an additional 103,177 shares during the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.